{"id":"https://openalex.org/W186127170","doi":null,"title":"[Clozapine withdrawal. A review].","display_name":"[Clozapine withdrawal. A review].","alternate_titles":[],"publication_year":1999,"publication_date":"1999-01-01","ids":{"openalex":"https://openalex.org/W186127170","mag":"186127170","pmid":"https://pubmed.ncbi.nlm.nih.gov/10786215"},"language":"pl","primary_location":{"id":"pmid:10786215","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10786215","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatria polska","raw_type":"English Abstract"},"parent_works":[],"lineage":["https://openalex.org/W186127170"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081690999","display_name":"Tomasz Szafra\u0144ski","orcid":"https://orcid.org/0000-0002-4181-3492","observed_orcids":["https://orcid.org/0000-0002-4181-3492"]},"institutions":[{"id":"https://openalex.org/I4210153937","display_name":"Institute of Psychiatry and Neurology","ror":"https://ror.org/0468k6j36","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210153937"]}],"countries":["PL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"T Szafra\u0144ski","raw_affiliation_strings":["III Kliniki Psychiatrii IPiN w Warszawie"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"III Kliniki Psychiatrii IPiN w Warszawie","institution_ids":["https://openalex.org/I4210153937"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002682329","display_name":"K Gmurkowski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"K Gmurkowski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"33","issue":"1","first_page":"51","last_page":"67"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clozapine-withdrawal","display_name":"clozapine withdrawal","score":0.9259999990463257},{"id":"https://openalex.org/keywords/antipsychotic-switching","display_name":"antipsychotic switching","score":0.8330000042915344},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.6010000109672546},{"id":"https://openalex.org/keywords/cholinergic-supersensitivity","display_name":"cholinergic supersensitivity","score":0.7160000205039978},{"id":"https://openalex.org/keywords/dopaminergic-supersensitivity","display_name":"dopaminergic supersensitivity","score":0.9679999947547913},{"id":"https://openalex.org/keywords/dopamine-d4-receptor","display_name":"dopamine D4 receptor","score":0.765999972820282},{"id":"https://openalex.org/keywords/neuroleptic-resistance","display_name":"neuroleptic resistance","score":0.8600000143051147},{"id":"https://openalex.org/keywords/thioridazine","display_name":"thioridazine","score":0.8019999861717224},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.9829999804496765},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":1.0},{"id":"https://openalex.org/keywords/benzamide","display_name":"benzamide","score":0.9449999928474426},{"id":"https://openalex.org/keywords/psychosis","display_name":"psychosis","score":0.5199999809265137}],"concepts":[{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.9631533622741699},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.6716245412826538},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.6626741290092468},{"id":"https://openalex.org/C2778062832","wikidata":"https://www.wikidata.org/wiki/Q498902","display_name":"Drug withdrawal","level":3,"score":0.567559540271759},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5284842252731323},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.48480239510536194},{"id":"https://openalex.org/C2780688371","wikidata":"https://www.wikidata.org/wiki/Q58375","display_name":"Thioridazine","level":3,"score":0.47861140966415405},{"id":"https://openalex.org/C2778689640","wikidata":"https://www.wikidata.org/wiki/Q113259","display_name":"Anticholinergic","level":2,"score":0.47069716453552246},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.46917396783828735},{"id":"https://openalex.org/C2910745098","wikidata":"https://www.wikidata.org/wiki/Q113259","display_name":"Anticholinergic agents","level":3,"score":0.45555222034454346},{"id":"https://openalex.org/C2775870346","wikidata":"https://www.wikidata.org/wiki/Q2554162","display_name":"Typical antipsychotic","level":5,"score":0.42793336510658264},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4168490469455719},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.39381134510040283},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.31780681014060974},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3177650570869446},{"id":"https://openalex.org/C2778775820","wikidata":"https://www.wikidata.org/wiki/Q407972","display_name":"Chlorpromazine","level":2,"score":0.30913227796554565},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2754943072795868},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2752135992050171}],"mesh":[{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011605","descriptor_name":"Psychoses, Substance-Induced","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:10786215","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10786215","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatria polska","raw_type":"English Abstract"},{"id":"mag:186127170","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10786215","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2023702380","https://openalex.org/W2012280140","https://openalex.org/W4382893262","https://openalex.org/W1995585472","https://openalex.org/W2137941062","https://openalex.org/W3199101600","https://openalex.org/W7064835291","https://openalex.org/W208049426","https://openalex.org/W2031952693"],"abstract_inverted_index":{"The":[0],"article":[1],"describes":[2],"the":[3,133],"symptoms":[4],"of":[5,7,36,48,76,80,87,91,100,143,157,163,197,209,220,222],"withdrawal":[6,44,64,90,99,134,156,196],"clozapine":[8,20,37,92,119,158,166],"and":[9,42,51,83,129,177,231],"their":[10],"possible":[11],"causes":[12],"as":[13,15],"well":[14],"research":[16],"on":[17],"switching":[18],"from":[19],"to":[21,33,60,94,125,182,193,227],"another":[22,245],"antipsychotic":[23,150,192],"drug.":[24],"A":[25],"computerised":[26],"search":[27],"was":[28],"conducted":[29],"using":[30],"MEDLINE":[31],"(1966-1997)":[32],"retrieve":[34],"reports":[35,41],"withdrawal.":[38,117],"Fifteen":[39],"case":[40,162],"sixteen":[43],"studies":[45],"(only":[46],"one":[47],"them":[49],"double-blind":[50],"two":[52],"single-blind)":[53],"were":[54],"identified.":[55],"Clozapine":[56],"multi-receptors":[57],"profile":[58],"seems":[59,93],"be":[61,95,121,136,170,175,180,244],"responsible":[62],"for":[63,111],"symptoms--several":[65],"specific":[66],"mechanisms":[67],"are":[68,187,203,234,240,250],"suggested:":[69],"cholinergic":[70,184],"supersensitivity,":[71],"dopaminergic":[72],"supersensivity,":[73],"special":[74],"role":[75],"D4":[77],"receptors,":[78],"possibilities":[79],"serotonergic,":[81],"noradrenergic":[82],"GABA-ergic":[84],"involvement.":[85],"Risk":[86],"relapse":[88,142],"after":[89,98,116,195],"greater":[96],"than":[97],"classical":[101,201,228],"neuroleptics.":[102],"Some":[103],"patients":[104],"might":[105,179,243],"become":[106],"de":[107],"novo":[108],"neuroleptic":[109],"resistant":[110],"at":[112],"least":[113],"several":[114],"weeks":[115],"Therefore,":[118],"should":[120,135],"stopped":[122],"only":[123,131],"due":[124],"strong":[126],"clinical":[127,218,248],"indications,":[128],"if":[130],"possible,":[132],"slow":[137],"(50":[138],"mg/week).":[139],"To":[140],"prevent":[141],"psychosis":[144],"some":[145],"experts":[146],"advocate":[147],"starting":[148],"new":[149],"drugs":[151],"in":[152,225],"therapeutic":[153],"dosage":[154],"before":[155],"is":[159,206,216],"completed.":[160],"In":[161,199],"emergency,":[164],"when":[165],"(high":[167],"dosage)":[168],"must":[169,174],"withdrawn":[171],"immediately,":[172],"patient":[173],"hospitalised":[176],"cholinergics":[178],"considered":[181],"prevent,":[183],"rebound\".":[185],"There":[186],"no":[188,217],"established":[189],"guidelines":[190],"which":[191],"choose":[194],"clozapine.":[198],"general,":[200],"antipsychotics":[202],"ineffective.":[204],"Thioridazine":[205],"suggested":[207],"because":[208],"its":[210],"prominent":[211],"anticholinergic":[212],"activity,":[213],"but":[214,237,247],"there":[215],"evidence":[219],"advantage":[221],"this":[223],"treatment":[224],"comparison":[226],"drugs.":[229],"Risperidon":[230],"especially":[232],"olanzapine":[233],"promising":[235],"possibilities,":[236],"initial":[238],"data":[239,249],"disappointing.":[241],"Benzamides":[242],"possibility":[246],"scarce.":[251],"These":[252],"important":[253],"issues":[254],"require":[255],"further":[256],"studies.":[257]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W186127170","counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
